Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-10

FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Spiriva HandiHalER (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, expanding the product's approved …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)

Snippet

SUPPL AP for SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)